Flyuorestsentnaya diagnostika predraka i nachal'nogo raka endometriya

E G Novikova , O V Chulkova , E V Filonenko , L G Putintseva , N N Bulgakova

Russian Journal of Oncology ›› 2010, Vol. 15 ›› Issue (2) : 25 -28.

PDF
Russian Journal of Oncology ›› 2010, Vol. 15 ›› Issue (2) : 25 -28. DOI: 10.17816/onco39710
Articles
other

Flyuorestsentnaya diagnostika predraka i nachal'nogo raka endometriya

Author information +
History +
PDF

Abstract

The results of fluorescence diagnosis using Alasens (3% solution, 10 ml into the uterine cavity) in 120 patients were analyzed. Group 1 consisted of 80 women admitted for primary examination for the diagnosis to be morphologically verified. Group 2 included 40 reproductive age patients previously diagnosed as having atypical endometrial hyperplasia and early cancer of the corpus uteri, in whom fluorescence diagnosis was made as monitoring of individual hormone therapy. Alasens exposure lasted 2 hours. By comparing the data of spectral fluorescence and morphological studies, in Group 1 the authors diagnosed atypical endometrial hyperplasia in 19 (23.8%) women, early cancer of the corpus uteri (cr in situ, stage Ia) in 46 (57.5%), and a benign process (glandular endometrial hyperplasia, polyps of the corpus uteri) in 15 (18.8%). In Group 2, disease recurrence was found in 6 (15%) women after hormonal therapy.

Keywords

Alasens / fluorescence diagnosis / spectrofluorometry / endometrial precancer / endometrial cancer

Cite this article

Download citation ▾
E G Novikova, O V Chulkova, E V Filonenko, L G Putintseva, N N Bulgakova. Flyuorestsentnaya diagnostika predraka i nachal'nogo raka endometriya. Russian Journal of Oncology, 2010, 15(2): 25-28 DOI:10.17816/onco39710

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Ашрафян Л. А., Харченко Н. В., Огрызкова В. Л. // Практич. онкол. - 2004. - Т. 5, № 1. - С. 16-23.

[2]

Берштейн Л. М. Гормональный канцерогенез. - М., 2000.

[3]

Бохман Я. В. Руководство по онкогинекологии. - СПб., 2002.

[4]

Новикова Е. Г., Чулкова О. В., Пронин С. М. Предрак и начальный рак эндометрия у женщин репродуктивного возраста. - М., 2005.

[5]

Пашков В. М., Лебедев В. А., Коваленко М. В. // Вопр. гин., акуш. и перинатол. - 2006. - Т. 5, № 3. - С. 51-59.

[6]

Чепик О. Ф. // Практич. онкол. - 2004. - Т. 5, № 1. - С. 9-15.

[7]

Чиссов В. И., Соколов В. В., Филоненко Е. В. // Рос. биотер. журн. - 2003. - Т. 2, № 4. - С. 45-56.

[8]

Якубовская Р. И., Казачкина Н. И., Кармакова Т. А., Шитова Л. А. // Рос. хим. журн. - 1998. - № 5. - С. 617-623.

[9]

Fehr M. K.,Wyss P., Tadir Y. // Am. J. Obstet. Gynecol. - 2002. - Vol. 175, N 5. - P. 1253-1259.

[10]

Hornung R., Fehr M. K., Major A. // Obstet. J. Am. Assoc. Gynecol. Laparosc. - 1998. - Vol. 5, N 4. - P. 367-374.

[11]

Lang K., Lehmann P., Bolsen K. // Expert Opin. Invest. Drugs. - 2001. - Vol. 72, N 10. - P. 829-837.

[12]

Nowis D., Makowski M., Legat M., Golab J. // Acta Biochim. Pol. - 2005. - Vol. 52, N 2. - P. 339-352.

[13]

Wyss P., Haller U., Berns M. W. // Biochim. Biophys. Res. Commun. - 2002. - Vol. 224, N 3. - P. 819-824.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

110

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/